🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Status
Completed
Location
Human Pharmacology Unit (UFH)
Start Date
2004-11-03
Trial ID
NCT03091868
Treatments Being Tested
The primary objective of this study is to explore the efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01515410
Treatments Being Tested
To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) exte...
Status
Completed
Location
Xenoscience, Inc. (102)
Start Date
2018-11-06
Trial ID
NCT03670953
Treatments Being Tested
This is a multi-center, randomized, double-blind, double-dummy, active cont...
Status
Active Not Recruiting
Location
Xenoscience
Start Date
2019-09-30
Trial ID
NCT04006210
Treatments Being Tested
The primary objective of this study was to demonstrate the superiority of l...
Status
Completed
Location
Site Reference ID/Investigator# 45719
Start Date
2009-01
Trial ID
NCT00357994
The purpose of this study is to assess the PK of AP-CD/LD given at dose of ...
Status
Unknown
Location
Multiple Locations
Start Date
2018-07
Trial ID
NCT03576638
Treatments Being Tested
This will be a single center, bioequivalence and food-effect, open-label st...
Status
Completed
Location
Syneous Health
Start Date
2019-07-15
Trial ID
NCT04236921
Treatments Being Tested
To investigate the effect of BIA 9-1067 in steady-state conditions on the l...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2009-03
Trial ID
NCT01533116
Treatments Being Tested
The study had three distinct parts and is described as follows: Part 1: *...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-08
Trial ID
NCT01411137
Treatments Being Tested